retatrutide korea approval vs. Tirzepatide retatrutide korea approval clinical trial

Why Hair Shedding Happens on GLP-1 Medications Hair grows in cycles, and when the body perceives stress, like rapid changes in weight or metabolism, it often shifts many hair follicles into a resting (telogen) phase

Safety Considerations Not everything works for everyone

Kbe T, Witte AV, Schnelle A, et al

Most patients have mild skin reactions, while severe (grade 3-4) toxicities are found in a low proportion of patients (5.8% for the ipilimumab + nivolumab combination, even lower values for anti-PD-1 monotherapy), significantly lower than the toxicities of other sites (such as hepatic or gastrointestinal) (129)